SOCS1 and SOCS3 proteins were initially described as onco-suppressors, being silenced in many tumors (42) as consequence of hypermethylation of their promoters or mutations influencing proliferation, differentiation and survival of immune cells controlling tumor expansion (107). The gene discussed is SOCS3; the disease is neoplasm.